Apoptosis (9)
Breast cancer (7)
apoptosis (5)
Photodynamic therapy (5)
prostate cancer (4)
sodium butyrate (4)
Eisenia foetida (3)
Laccase (3)
5-Aminolevulinic acid (2)
breast cancer (2)
Canine mammary gland tumor (2)
coelomic fluid (2)
combination effect (2)
cytotoxicity (2)
Drug delivery (2)
ephitelial cell (2)
miRNA (2)
oxidative stress (2)
protective effect (2)
toll-like receptor 4 (2)
toxicity (2)
ZIF-8 (2)
5-aminolaevulinic acid (1)
5-aminolaevulinic acid | Apoptosis | Canine mammary gland tumor | Carcinoma | Carcinosarcoma | Photodynamic therapy (1)
5-aminolevulinic acid (1)
5-Aminolevulinic acid | Apoptosis | Canine mammary gland tumor | Photodynamic therapy (1)
5-Aminolevulinic acid | Apoptosis | Canine mammary tumors | Photodynamic therapy (1)
5-Sulfosalicylic acid (1)
Abemaciclib | Apoptosis | CDK4/6 | Prostate cancer (1)
AKT (1)
Anti-cancer (1)
Anti-cancer | Cancer | Endometrial adenocarcinoma | Enzyme | Laccase | Thyroid (1)
anticancer activity (1)
anticancer activity | colorectal cancer | Laccase | ROS | three-phase partitioning (1)
anti-cancer agent (1)
anti-cancer agent | breast cancer | cytotoxicity | phthalocyanine | prostate cancer | water-soluble (1)
Anticancer effect (1)
Anticancer effect | Antiproliferative | Cancer therapy | Coleomic fluid | Colon cancer | Eisenia foetida (1)
Anticancer effect | Apoptosis | Breast cancer | Genistein | TLR3 (1)
anticancer effect | apoptosis | feline squamous cell carcinoma | iscador | Viscum album (1)
apoptosis | autophagy | breast cancer | CA3 (CIL56) | DNA repair | hippo pathway | metabolic reprogramming | proteomics | yes-associated protein (YAP) (1)
apoptosis | bee venom | honey bee | triple negative breast cancer (TNBC) (1)
Apoptosis | Cabazitaxel | Castration resistant metastatic prostate cancer cells | Drug resistance | Taxanes (1)
Apoptosis | Cabazitaxel | Taxanes | Toll like receptor 3 | Toll like receptors (1)
apoptosis | canine mammary gland tumour | histone deacetylase inhibitor | sodium butyrate (1)
Apoptosis | Coelomic fluid | Eisenia foetida | Prostate Cancer (1)
apoptosis | combination effect | prostate cancer | rutin | sodium butyrate (1)
Apoptosis | Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) | Talazoparib | TLR3 | TLR9 | Toll-like receptors (TLRs) (1)
Apoptosis | prostate cancer | sodium butyrate | toll-like receptor 4 (1)
B activity (1)
bacterial eye infections (1)
bacterial eye infections | cell culture techniques | conjunctival diseases | eye diseases (1)
BALB/c mice (1)
bee venom (1)
Biochemical characterization (1)
Biochemical characterization | Breast cancer cells | Commercial laccase | Laccase | Three-phase partitioning (1)
Biomarker (1)
Biomarker | Cell cycle | Metastasis | MiRNA | Prostate cancer (1)
bisphenol M (1)
Boron (1)
Boron | Prostate cancer | Proteomics | Sodium pentaborate pentahydrate (SPP) | Sodium perborate tetrahydrate (SPT) (1)
Boswellic acid (1)
Breast cancer | chemo-protective effect | Eisenia foetida | ROS (1)
Breast cancer | combination effect | quercetin | sodium butyrate (1)
Breast cancer | Comet assay | Nitric oxide | Sodium butyrate (1)
Breast cancer | Drug delivery | Gallic acid | Gemcitabine | ZIF-8 (1)
Breast Cancer | Epidermal Mesenchymal Transition | IL-6 | Tamoxifen (1)
Breast cancer | Exosomes | PI3K/AKT/mTOR signaling | Receptor tyrosine kinases (1)
Breast cancer cells (1)
cabazitaxel (1)
Cabazitaxel (1)
California worm (1)
California worm | Cell viability | Guanidine | HUVEC | Type-2 Diabetes (1)
Cancer (1)
canine mammary gland tumour (1)
Canine mammary tumors (1)
Carcinoma (1)
Carcinosarcoma (1)
Castration resistant metastatic prostate cancer (1)
cell culture techniques (1)
cell cycle (1)
Cell cycle (1)
Cell viability (1)
cells (1)
Coelomic fluid (1)
Colon cancer (1)
Colon cancer | Density functional theory | Photodynamic therapy | Photosensitizer | Phototoxicity | Phthalocyanine | Singlet oxygen (1)
colorectal cancer (1)
Colorectal cancer (1)
Combined therapy (1)
Combined therapy | Meclofenamic acid (MA) | Small cell lung carcinoma (SCLC) | Synergism | Topotecan (TPT) (1)
Commercial laccase (1)
complete response (1)
conjunctival diseases (1)
Curcumin (1)
cytotoxicity | genotoxicity | nasal mucosal cells | octenidine dihydrochloride (1)
Density functional theory (1)
Drug resistance (1)
Endometrial adenocarcinoma (1)
Enzyme (1)
Exosomes (1)
eye diseases (1)
Feline mammary gland tumor (1)
Gallic acid (1)
Gemcitabine (1)
Genistein (1)
genotoxicity (1)
glycolysis (1)
glycolysis | metabolic plasticity | metabolic reprogramming | Metabolic Rheostat Index | oxidative phosphorylation | pancreatic ductal adenocarcinoma | single-cell RNA sequencing | tumor microenvironment (1)
Guanidine (1)
hepatitis B (1)
hepatitis B | hepatitis B vaccine response | metabolic dysfunction-associated steatotic liver disease | miRNA (1)
Hepatitis B | NF‑kB | pro-inflammatory cytokines | systemic inflammation | vaccine response (1)
hepatitis B vaccine response (1)
hepatotoxicity (1)
histone deacetylase inhibitor (1)
honey bee (1)
HUVEC (1)
Immunodysregulation (1)
Immunodysregulation | lymphoma | PEPD gene | prolidase deficiency (1)
Key Anticancer effect Antiproliferative Cancer therapy Coleomic fluid Eisenia foetida Colon cancer (1)
Light-emitting diodes (LEDs) (1)
Liver metastasis (1)
lymphoma (1)
Meclofenamic acid (MA) (1)
metabolic dysfunction-associated steatotic liver disease (1)
metabolic plasticity (1)
metabolic reprogramming (1)
Metabolic Rheostat Index (1)
metastasis (1)
Metastatic castration-resistant prostate cancer (1)
MiR-135b (1)
MiR-99b (1)
MiRNA (1)
MiRNA | Surgical treatment | Thyroid cancer (1)
mitochondrial dysfunction (1)
MMPs (1)
mTOR signaling (1)
nasal mucosal cells (1)
NF-κ (1)
octenidine dihydrochloride (1)
oxidative phosphorylation (1)
pancreatic ductal adenocarcinoma (1)
PEPD gene (1)
Peritonitis carcinomatosis (1)
Photosensitizer (1)
Phototoxicity (1)
phthalocyanine (1)
Phthalocyanine (1)
PI3K (1)
prolidase deficiency (1)
Prostate cancer (1)
Prostate Cancer (1)
Proteomics (1)
quercetin (1)
Receptor tyrosine kinases (1)
ROS (1)
rutaecarpine (1)
rutin (1)
single-cell RNA sequencing (1)
Singlet oxygen (1)
Small cell lung carcinoma (SCLC) (1)
Sodium pentaborate pentahydrate (SPP) (1)
Sodium perborate tetrahydrate (SPT) (1)
subtype (1)
Surgical treatment (1)
Synergism (1)
Taxanes (1)
three-phase partitioning (1)
Three-phase partitioning (1)
Thyroid (1)
Thyroid cancer (1)
TIMPs (1)
TLR3 (1)
Topotecan (TPT) (1)
triple negative breast cancer (TNBC) (1)
tumor microenvironment (1)
Type-2 Diabetes (1)
water-soluble (1)
